3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
50
Prostatic Neoplasms
44
Multiple Myeloma
22
Neoplasm Metastasis
17
Osteoporosis
14
Pain
11
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasms, Plasma Cell
5
Lung Neoplasms
5
Bone Diseases, Metabolic
5
Fractures, Bone
4
Bone Diseases
4
Lymphoma
3
Carcinoma, Renal Cell
3
Bone Neoplasms
3
Spinal Cord Compression
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Kidney Neoplasms
2
Humoral Hypercalcemia Of Malignancy
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Renal Insufficiency
1
Recurrence
1
Pleural Effusion, Malignant
1
Interventions
Zoledronic Acid
1
Surveys and Questionnaires
1
Range of Motion, Articular
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Injections, Intra-Articular
1
Functional Status
1
Ferrosoferric Oxide
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Osteonecrosis
×
Zoledronic Acid
×
Clear all
NCT02286830
2023-02-17
Magnolia
Odense University Hospital
Phase 4
Completed
158 enrolled